FDA Inspection 878735 — Bell International Laboratories, Inc.
The FDA completed an inspection of Bell International Laboratories, Inc. on May 14, 2014 in Eagan, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 14, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Eagan, MN (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)